- Home
- VINO vs PTIX Comparison
VINO vs PTIX Comparison
Compare VINO & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINO
- PTIX
- Stock Information
- Founded
- VINO 1999
- PTIX 1994
- Country
- VINO United States
- PTIX United States
- Employees
- VINO N/A
- PTIX N/A
- Industry
- VINO Real Estate
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- VINO Finance
- PTIX Health Care
- Exchange
- VINO Nasdaq
- PTIX Nasdaq
- Market Cap
- VINO 4.4M
- PTIX 3.6M
- IPO Year
- VINO N/A
- PTIX 2016
- Fundamental
- Price
- VINO $4.36
- PTIX $0.58
- Analyst Decision
- VINO
- PTIX
- Analyst Count
- VINO 0
- PTIX 0
- Target Price
- VINO N/A
- PTIX N/A
- AVG Volume (30 Days)
- VINO 17.6K
- PTIX 713.0K
- Earning Date
- VINO 11-15-2024
- PTIX 11-12-2024
- Dividend Yield
- VINO N/A
- PTIX N/A
- EPS Growth
- VINO N/A
- PTIX N/A
- EPS
- VINO N/A
- PTIX N/A
- Revenue
- VINO $2,006,876.00
- PTIX N/A
- Revenue This Year
- VINO N/A
- PTIX N/A
- Revenue Next Year
- VINO N/A
- PTIX N/A
- P/E Ratio
- VINO N/A
- PTIX N/A
- Revenue Growth
- VINO 1.79
- PTIX N/A
- 52 Week Low
- VINO $3.89
- PTIX $0.50
- 52 Week High
- VINO $13.50
- PTIX $1.87
- Technical
- Relative Strength Index (RSI)
- VINO 37.53
- PTIX 43.04
- Support Level
- VINO $4.00
- PTIX $0.56
- Resistance Level
- VINO $5.81
- PTIX $0.65
- Average True Range (ATR)
- VINO 0.54
- PTIX 0.07
- MACD
- VINO -0.01
- PTIX -0.00
- Stochastic Oscillator
- VINO 19.94
- PTIX 16.83
About VINO Gaucho Group Holdings Inc.
Gaucho Group Holdings Inc develops and operates real estate projects in Argentina. It operates a hotel, golf and tennis resort, vineyard and producing winery in addition to developing residential lots located near the resort. The company operates in three segments which are the business of real estate development and manufacture; the sale of high-end fashion and accessories through an e-commerce platform; corporate operations. It derives majority of its revenue from the Real Estate Development segment.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.